Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Open Forum Infectious Diseases|July 8, 2024
A Multicenter Retrospective Study Evaluating Intravenous to Oral Antibiotic Stepdown for Uncomplicated Streptococcal BacteremiaAlison K Lew, Madison E Salam, Alan E Gross, et al.Frontiers in Medicine|November 16, 2020
IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary InfectionsLucas M Kimmig, David Wu, Matthew Gold, et al.Medrxiv : the Preprint Server for Health Sciences|September 16, 2020
IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infectionsLucas M Kimmig, David Wu, Matthew Gold, et al.BMC Infectious Diseases|June 3, 2021
Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admissionNatasha N Pettit, Cynthia T Nguyen, Alison K Lew, et al.Infection Control and Hospital Epidemiology|June 29, 2018
Improved rates of antimicrobial stewardship interventions following implementation of the Epic antimicrobial stewardship moduleNatasha N Pettit, Zhe Han, Anish R Choksi, et al.The American Journal of Emergency Medicine|March 30, 2021
The effect of delays in second-dose antibiotics on patients with severe sepsis and septic shockJoseph D Lykins V, Hani I Kuttab, Erron M Rourke, et al.The Journal of Antimicrobial Chemotherapy|May 6, 2017
Multicentre study of posaconazole delayed-release tablet serum level and association with hepatotoxicity and QTc prolongationNatasha N Pettit, Marisa H Miceli, Christina G Rivera, et al.Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19Garth W Strohbehn, Brian L Heiss, Sherin J Rouhani, et al.Clinical Pharmacology and Therapeutics|November 19, 2020
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 PneumoniaGarth W Strohbehn, Brian L Heiss, Sherin J Rouhani, et al.Pageof 5